Carb-X

EFPIA - Pandemic Prevention: how Europe can lead the fight against AMR
2021-11-16 08:00 - 09:30 (America/New_York) | VIRTUAL EVENT
You’re invited to join this virtual event on Tuesday, 16 November, 2021 at 14:00 – 15:30 CET.
The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not.
The World Bank estimates that 10 million people per year could die if new antimicrobials are not found. Without effective prevention and treatment of infections, medical procedures such as organ transplantation, cancer chemotherapy, and major surgery will become too dangerous to perform. In the Pharmaceutical Strategy for Europe, the European Commission declared that “new business models are required” if we are to meet this challenge and succeed, spotlighting 2022 as the year when change needs to happen.

Join us to discuss how we can drive investment in antimicrobials R&D and set out a roadmap to a sustainable innovation ecosystem that will safeguard society against the threat of AMR.

CARB-X participants include Kevin Outterson, Executive Director.
Click here to learn more and register.

3rd SCI-RSC Symposium on Antimicrobial Drug Discovery
2021-11-15 - 2021-11-16 | SCI, 14/15 Belgrave Square, London, SW1X 8PS, United Kingdom
At a time when antimicrobial resistance is decreasing the efficacy of existing treatments, it has never been more important that we refresh the drug pipeline with new therapeutics acting on new targets or exhibiting novel modes of action.
Fortunately, renewed interest from both industry and academia has led to a resurgence in antimicrobial drug discovery and interest in developing innovative technologies and approaches for combating infection.
Coinciding with WHO’s World Antibiotics Awareness week, this two-day meeting will examine the latest advances in antimicrobial drug discovery from a medicinal chemist’s perspective, focusing on the particular challenges associated with developing antimicrobials whilst also showcasing emerging strategies for tackling infection.
Bringing together leading exponents in the field from industry and academia, the meeting will appeal to anyone with an interest in antimicrobial resistance and antimicrobial drug discovery. And with great opportunities for academic–industrial partnerships, researchers from both sectors will also benefit from the networking opportunities that the meeting will offer.
Click here to learn more.
Email conferences@soci.org to register your interest.
Conference Team
Tel: +44 (0)20 7598 1561
Email: conferences@soci.org

9th ASM Conference on Biofilms
2021-11-14 - 2021-11-18 | Charlotte, North Carolina
The 9th ASM Conference on Biofilms will be coming to Charlotte, N.C. on Nov. 14 –18, 2021. Additional Details Forthcoming.
Biofilms have a tremendous impact on industrial, clinical and natural environments. 2021 ASM Biofilms will provide an interdisciplinary platform to discuss the latest biofilm research. Check back later for more details about the meeting. We look forward to seeing you next year.
Click here to learn more.
Click here to view the agenda.

World Antimicrobial Resistance Congress 2021
2021-11-08 - 2021-11-09 | Washington DC
Antimicrobial resistance (AMR) is one of the biggest global health crises facing the world today. The number of deaths attributed to AMR is expected to surpass the number of deaths from cancer worldwide by 2050. Yet combatting resistance globally and developing a robust arsenal of antibiotics continues to fall behind the pace of resistance.
Since 2015, the World Anti-Microbial Resistance Congress has been the go-to conference globally for all stakeholders in the AMR space to meet, brainstorm ideas and formulate initiatives that can effectively tackle this pressing issue.
Industry leaders, innovative technology and solution providers, public authorities, international organizations, infectious disease clinicians, pharmacists and microbiologists are some of the 1,000+ attendees from over 50 countries who will gather this November 2021 at the World Anti-Microbial Resistance Congress.
The conference will gather global leaders in infectious diseases to meet, brainstorm and discuss the challenges and opportunities on the following areas:

Advancing antibiotic R&D and non-traditional therapies development
Enhancing the commercial landscape and marketplace for antibiotics and diagnostics
Developing innovative diagnostics solutions
Facilitating interactions between funders and developers
Improving antimicrobial stewardship guidelines and practice through technology
Implementing sustainable environmental and manufacturing practices
Tackling infection control at hospitals efficiently and cost-effectively
Applying genomics to easily detect resistant pathogens and to accelerate antibiotic R&D
Leveraging surveillance platforms and solutions to monitor outbreaks and increasing numbers of resistant pathogens locally, regionally, nationally and globally.

If you work in these key areas of AMR, then you must attend the World Anti-Microbial Resistance Congress 2021!
Click here to learn more.
Click here to view the agenda.
Click here to register.

BARDA Industry Day
2021-11-03 - 2021-11-04
BARDA Industry Day is the annual meeting held to increase potential partner’s awareness of U.S. Government medical countermeasure priorities, interact with BARDA and ASPR staff, and network with public and private sector colleagues working in the Health Security space.
Additional details forthcoming.

World Health Summit
2021-10-24 - 2021-10-26 | Berlin, Germany
The World Health Summit promotes a science-driven and broad approach to global health development with the Sustainable Development Goals (SDGs) at its core. Our key issues are therefore interdisciplinary, science-based, cross-sectoral, and concerted. They are vital to set the global health agenda for the years to come. Because health is more than medicine and health is a human right. Key issues include:

Access to Essential Medicine
Big Data
Biomedical Research
Climate Change and Health
Digital Innovation
Drugs and Vaccines
Evolutionary Medicine
Global Action Plan for Healthy Lives and Well-being for All
Global Health Security
Health in All Policies
Health Systems Strengthening
Pandemic Preparedness
Patient Safety
Planetary Health
Sustainable Development Goals (SDGs)
Translational Science
Universal Health Coverage

Click here to learn more.

CARB-X WEBINAR: European Celebration of 5 Years of Progress with CARB-X
2021-10-22 09:30 - 10:30 (America/New_York) | WEBINAR, Webinar, Webinar, United States
European Celebration of 5 Years of Progress with CARB-X
A virtual discussion of progress and plans to accelerate innovation globally
22nd of October, 2021, 3:30 – 4:30pm CET / 9:30 – 10:30am ET
Antibiotic-resistance undermines the safety net for modern medicine. Chemotherapy, surgeries, transplantation, childbirth – all of these and more depend on antibiotics to treat infection. At least 700,000 people die each year due to antibiotic-resistant (AMR) infections, according to a recent WHO report. A recent Lancet publication from the European Center for Disease Prevention and Control (ECDC) estimates that approximately 33,000 deaths in the EU each year can be attributed to AMR, and an Organization of Economic Cooperation & Development OECD report calculates about 1.1 billion Euros are required for the health care systems of EU/EEA countries to address AMR.
CARB-X and its partners are taking action. CARB-X has funded 92 projects in 12 countries totaling more than $360 million since it launched in 2016. In Europe, the support of Wellcome Trust, the German Ministry of Health and Education, and the UK Global AMR Innovation Fund was critical to this progress over the past five years.
Today, the CARB-X portfolio is the world’s largest and most scientifically diverse antibacterial R&D portfolio. We are currently accelerating projects focused on the most serious antibiotic-resistant bacteria, including new classes of antibiotics and non-traditional agents, vaccines and other preventatives such as CRISPR-phage, microbiome-modifying agents and antibodies, and rapid diagnostics.
Please join us for a virtual discussion of the critical role that CARB-X and its global partners play in driving the development of innovative products to address the antibiotic-resistant bacteria health crisis.
CARB-X Executive Director Kevin Outterson will highlight achievements, especially in Europe and speak to CARB-X’s future vision and strategy.
European-based funders of CARB-X will outline their objectives and strategy in preparedness and how CARB-X delivery over 2016-2021 has met some of these goals.
Several European product developers in the current CARB-X portfolio will speak about their innovative products and their experience working with CARB-X.
A panel of experts will discuss antibiotics as the safety net for modern medicine and the challenges of bringing innovative products to patients in Europe.

Veronika von Messling – Director-General for Life Sciences at the German Federal Ministry of Education and Research (confirmed)
Florence Séjourné – Chief Executive Director of Da Volterra and President of BEAM Alliance (confirmed)
Sir Jeremy Farrar – Director of Wellcome Trust & Member of the One Health Global Leaders Group on AMR (confirmed)
Otto Cars – Founding Director of ReAct, Senior Professor, Infectious Diseases, Uppsala University, and former member of UN Inter-Agency Coordination Group on AMR (confirmed)

Click here to register, and to find out more about this important virtual meeting.

ID Week 2021
2021-10-22 - 2021-10-25 | San Diego, Venue Forthcoming, CA, United States
Click here to learn more, additional details forthcoming.

ICARe Interdisciplinary Course on Antibiotics and Resistance
2021-10-16 - 2021-10-24 | Les Pensieres, Annecy, France
The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is currently no course providing advanced instruction on antibiotics and resistance. The specific goal of ICARe is to bring leaders in academics and industry together with trained scientists at the dawn of their careers. Cutting-edge approaches for the study of resistance and antibiotic discovery will be examined.
The objective of ICARe is to train the next generation of scientists implicated in the study of bacterial resistance to antibiotics and the finding of new drugs. ICARe is designed for assistant professors, new industry scientists, ID fellows, and postdoctoral research associates, as well as members from developing areas contending with the challenge of managing antibiotic resistance with limited resources. Attendance will be limited to 40 students and will reflect the global nature of the problem.
Click here to learn more.
Click here to view an overview of the programme.

Partnership to Fight Infectious Disease - Preparing for the Next Pandemic: An International Discussion
2021-10-06 08:00 - 09:00 (America/New_York) | Webinar
The Partnership to Fight Infectious Disease is convening a discussion among international experts to help inform domestic and international pandemic preparedness strategies building on lessons learned from the COVID-19 pandemic and other experiences.
CARB-X participants include Kevin Outterson, Executive Director, who will moderate the discussion.
Click here to learn more.
Click here to register.

Vaccinology in Africa Course 4-15 October 2021 (Online)
2021-10-04 - 2021-10-15 | VIRTUAL EVENT
The course provides state-of-the-art teaching in both human and veterinary vaccinology, drawing on the experience of the Jenner Institute at the University of Oxford, The Pirbright Institute, and this year’s African host, the KEMRI Wellcome Trust Research Programme in Kenya. These courses alternate between East and West Africa. In 2021, participation is limited to attendants currently working or studying in East Africa. Applications close 31 August 2021.
Click here to learn more.

North American Cystic Fibrosis Conference (NACFC) 2021
2021-09-30 - 2021-10-02 | San Antonio, Texas
The North American Cystic Fibrosis Conference (NACFC) is organized by the Cystic Fibrosis Foundation (CFF). The CFF 2021 onsite medical conference will be held from September 30 – October 2, 2021, in San Antonio Texas. Additional details forthcoming.
Click here to learn more.

The Vaccines Against Shigella and ETEC (VASE) Conference
2021-09-28 - 2021-09-30 | VIRTUAL EVENT
This is an international gathering dedicated to developing Shigella and enterotoxigenic Escherichia coli (ETEC) vaccines, hosted by PATH, a global nonprofit dedicated to achieving health equity.
Registration is now open for the VASE Virtual Symposium, which will be held online on 28 and 30 September 2021. Check out the full agenda and read the presentation abstracts. This fully virtual event will provide key updates on vaccines being developed for Shigella, (ETEC) and other emerging diarrheal pathogens, such as non-typhoidal Salmonella.
Click here to learn more.

18th International Conference on Pseudomonas
2021-09-27 - 2021-10-02 | Atlanta, Georgia
The scientific sessions include Genomics and gene regulation; Antimicrobial tolerance; Host-Pathogen interactions; Metabolism and Physiology; Harnessing the Potential of Pseudomonas species; Evolution and Coevolution; Ecology; and Multi-species Interactions.
Plenary Speaker: Fiona Brinkman, Canada, Fellow of the Royal Society of Canada
Keynote Speakers: Joseph Bondy-Denomy, Paul Turner, Barbara Kazmierczak, Gregg Beckham, Wei Huang, Jenna Gallie, Britt Koskella, and Jessica Scoffield
Click here to learn more.
Click here to view the agenda.
Click here to register.

2021 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
2021-09-21 - 2021-09-24 | Boston, Venue Forthcoming, Boston, MA, United States
The ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance, scheduled to take place on Sept. 1-4, 2020 in Dublin, Ireland, has been cancelled due to the COVID-19 pandemic. Visit the ESCMID website for more details. The 2021 conference will take place on Sept. 21-24 in Boston, Mass.
Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug development for AMR.
Additional details forthcoming.
Click here to learn more, additional details forthcoming.

BLUE KNIGHT™ Webinar: Antimicrobial Resistance – Breakthrough Innovation and Breaking Barriers
2021-09-15 10:00 - 11:00 (America/New_York) | VIRTUAL EVENT
As multi-drug resistant bacteria become increasingly threatening to global public health and existing antibiotics are becoming ineffective, the global community of public and private organizations and life science innovators are rallying around the Antimicrobial Resistance challenge.
Johnson & Johnson Innovation has invited leading experts in the field to share their views. Why aren’t (enough) new antibiotics being developed to address the AMR challenge? What other innovations might help without increasing antibiotic resistance?
Join the discussion as thought leaders share their views on the challenges surrounding this global health threat and the potential solutions.
Topics will include:

Priority MDR bacterial pathogens of interest
Potential interventions to prevent and treat MDR bacterial infections
Barriers in the development and commercialization pathway
The need for policy change to address these barriers
The potential roles of various organizations and public-private partnerships

*This program is part of BLUE KNIGHT™, a collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA).
Click here to learn more.
Click here to view the agenda.
Click here to register.

American Academy of Orthopaedic Surgeons (AAOS) 2021 Annual Meeting
2021-08-31 - 2021-09-03 | San Diego, California
Click here to learn more.
Click here to register.

Public Workshop: Science and Regulation of Bacteriophage Therapy
2021-08-30 - 2021-09-01 | VIRTUAL EVENT
The Food and Drug Administration (FDA), Center for Biologics Evaluation and Research, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases are announcing a public workshop entitled “Science and Regulation of Bacteriophage Therapy.” The purpose of the public workshop is to exchange information with the medical and scientific community about the regulatory and scientific issues associated with bacteriophage therapy.
Click here to learn more.
Click here to view the agenda.
Click here to register.

Global Conference on Vaccines Research and Development
2021-08-26 - 2021-08-28 | Paris, France
The conference aims to empower future generations in different fields of Vaccinology to explore exciting research outcomes that lie in tune with the objectives and theme of this exciting event. It further helps you enhance your understanding of commercial, scientific and regulatory issues that affect strategic decision making in the Vaccine Sector.
This global conference sets the stage for brain-storming discussions among the participants with its enriching Q&A sessions, round table discussions and technical workshops and provides know-how of the latest methodologies and technicalities of Vaccines. Inspiring and educating talks from eminent scientists together with keynote lectures, plenary sessions, and video and poster presentations that span across the length and breadth of this conference.
We look forward to seeing you at Vaccines Conference-2021 in Paris, France.
Click here to learn more.
Click here to view the agenda.
Click here to register.

BIOCOM 5th AMR Conference 2021 – Summer Edition: AMR Briefing Sessions
2021-08-24 08:00 - 2021-08-26 17:00 (America/New_York) | VIRTUAL EVENT
The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.
The “AMR Conference” was started in 2017 as part of the annual “Berlin Conference on Life Sciences” series which was established by BIOCOM AG twelve years ago as an event format to discuss the challenges of SME-driven innovation for the health market and to offer a platform for meeting experts from business, science, clinics, finance, regulatory affairs and intellectual property.
Each day will offer an AMR briefing session in the afternoon (starting at 2pm CET) on a dedicated topic, including live speakers, high-level panel discussions, and interactive exchange with the audience:

Day 1 – Status quo & COVID-19 Impact: What has changed after one year of COVID?
Day 2 – Financing & Investing: What’s new with funds, incubators and accelerators?
Day 3 – Policy & Incentives: What can we learn from best practices to go ahead?

CARB-X participants include Erin Duffy, Chief of R&D, who is a speaker on the session “Focus on incubators and public-private accelerators in US and Europe – How they drive the AMR innovation pipeline” on Wednesday, August 25th at 3:00 p.m. – 4:15 p.m. CEST, and Kevin Outterson, Executive Director, who is a speaker on the session “What can we expect and learn from the US and UK pull incentive initiatives?” on Thursday, August 26th at 02:00 p.m. – 03:15 p.m. CEST
Click here to learn more.
Click here to view the agenda.
Click here to register.

The World Economic Forum Special Annual Meeting - 2021 Singapore
2021-08-17 08:00 - 2021-08-21 17:00 (America/New_York) | Singapore
The World Economic Forum Special Annual Meeting 2021 in Singapore will convene on 17-20 August. The meeting follows the success of the Forum’s virtual Davos Agenda in January, which brought together world leaders from government, business and society.

The Special Annual Meeting 2021 was scheduled for 25-28 May. Although the World Economic Forum and Government of Singapore remain confident of the measures in place to ensure a safe and effective meeting, and local transmission of COVID-19 in Singapore remains at negligible levels, the change to the meeting’s timing reflects the international challenges in containing the pandemic. Current global travel restrictions have made planning difficult for an in-person meeting in the first half of the year. Furthermore, differing quarantine and air transport regulations have increased the lead time necessary to ensure that participants globally can make arrangements to join.

The Special Annual Meeting 2021 in Singapore in August will be the first global leadership summit to address the challenges of recovering from the pandemic and laying the basis for a more inclusive and sustainable world. It will bring leaders face-to-face to focus on shaping solutions to the most pressing challenges of our times.

“A global leadership summit needs the participation of all global stakeholders,” said Klaus Schwab, Founder and Executive Chairman of the World Economic Forum. “The Special Annual Meeting in Singapore in August will provide the place for leaders from business, government and civil society to come together to address the steps for global recovery.”

Click here to learn more.

Gordon Research Conference: Staphylococcal Diseases
2021-08-15 - 2021-08-20 | Grand Summit Hotel at Sunday River, 97 Summit Road, Newry, ME, United States
The description for this conference is being developed by the conference chairs. Please check back regularly for updates to this information.
Click here to learn more.

Innovations for Tackling Tuberculosis in the Time of COVID-19: A Two-Part Virtual Workshop
2021-07-22 11:00 - 13:00 (America/New_York) | VIRTUAL EVENT
Register now: Innovations for Tackling Tuberculosis in the Time of COVID-19: Part One of a Two-Part Workshop (July 22, 11 AM – 1 PM ET)
This public workshop is the first in a two-part series that examines the innovations needed to meet the targets for ending tuberculosis (TB) set by the WHO End TB Strategy for 2030 and affirmed by the United Nations High-Level Meeting on the Fight Against Tuberculosis. The workshop will feature presentations and discussions that will consider emerging technologies in diagnostic testing and vaccine development, improvements in TB treatment, and how to ensure increased and sustained commitments to reach the goal of ending TB in high burden countries despite the challenges from COVID-19.
This first session will provide an update on the current status, unmet needs, and promising advances in diagnostics, vaccines and therapeutics, and the critical need for new business models in sustainably combating TB.
CARB-X participants include Kevin Outterson, Executive Director, who will be a speaker during the workshop.

Click here to learn more.
Click here to view the agenda.
Click here to register.

BSAC and LP Webinar: Diagnostic driven strategies for antimicrobial resistance in the UK
2021-07-20 16:30 - 18:00 (Europe/London) | WEBINAR, Webinar, Webinar, United States
BSAC Infection Clinical Dilema Series
Webinar: Diagnostic driven strategies for antimicrobial resistance in the UK

Longitude Prize is partnering with British Society for Antimicrobial Chemotherapy (BSAC) for the Infection Clinical Dilemmas webinar series. It will bring diagnostic developers together with clinicians and professional bodies working on diagnostic evaluation in and for the National Health Service (NHS) in the UK, to build an understanding of the NHS commissioning path for AMR diagnostic tests. The event will include presentations by the Head of AMR at NHS England and National Institute for Health and Care Excellence (NICE), followed by an interactive ‘Ask an Expert’ session – with experts from Medicines and Healthcare products Regulatory Agency (MHRA), University of Oxford NIHR Community Healthcare MedTech and IVD Cooperative and clinicians – for developers to express challenges they face and ask questions about marketing access in the UK.

The webinar will take place on Tuesday 20th July, 1630-1800hrs BST
Click here to sign-up and register.

31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
2021-07-09 - 2021-07-12 | Virtual Event, 765 Commonwealth Avenue, Boston, MA, 02215, United States
We invite you to the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which will take place in Vienna, Austria and virtually from 9 – 12 July 2021. This is the first time the event will take place in summer. ECCMID, the world’s premier Clinical Microbiology & Infectious Diseases event, brings together experts from relevant fields to present the latest findings and developments and share their expertise. The congress will take place in the beautiful city of Vienna at the Reed Messe Conference Centre, as well as online, allowing us to create a unique experience to all delegates regardless of the mode of participation. The programme committee has developed a multi-faceted programme to incorporate all of the exciting educational, social and professional events that ECCMID has to offer.
To learn more, click here.
To view the program, click here.
To register, click here.

Advances in Antimicrobial Innovation Scientific meeting
2021-07-05 08:00 - 12:00 (America/New_York) | VIRTUAL EVENT
This Royal Society conference will bring together scientists, medical practitioners and funding bodies to raise awareness and interest for new anti-microbial advances.
Anti-microbial resistance continues to grow as a worldwide health challenge. Pathogens are continually evolving to combat drugs given to treat potentially life-threatening diseases, rendering treatments ineffective and threatening the many advances in fighting microbes over recent decades.
As therapeutics in current use become less effective, new approaches are required. This event aims to raise awareness and interest for new anti-microbial advances, the challenges faced in market delivery, and their appropriate use in healthcare systems.
About the conference series:
The conference is part of the Royal Society’s Transforming our future conferences in the life sciences, supported by AstraZeneca. These meetings are unique, high-level events that address the scientific and technical challenges of the next decade. Each conference features cutting edge science from industry and academia and brings together leading experts from the scientific community, including regulatory, charity and funding bodies. This conference also forms part of the Academy of Medical Sciences’ FORUM programme.
CARB-X participants include Erin Duffy, Chief of R&D, who will participate in the session ‘Challenges of prescribing, diagnostics and antibiotic education, investment and building a business model for new antibiotics’ between 3.30pm – 4.30pm EST.
Click here to learn more.
Click here to register.

Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) Virtual Public Meeting
2021-06-29 - 2021-06-30 | VIRTUAL EVENT
The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) provides advice, information, and recommendations to the Secretary regarding programs and policies intended to support and evaluate the implementation of U.S. government activities related to combating antibiotic-resistant bacteria.

At the June 29-30, 2021 Virtual Public Meeting, the PACCARB will deliberate and vote on two reports to transmit to the Secretary of Health and Human Services, the first from the Disparities in Antibiotics Access and Use Working Group, and the second from the Working Group on Antimicrobial Resistance (AMR) in Inter-Professional Education. The remainder of the 2-day public meeting will include an update on the status of the antibiotic development pipeline and an open council discussion on provocative questions in AMR (no recommendations will be made), in addition to presentations on Operationalizing One Health and the Environmental Dimensions of AMR.
Date and Time:
June 29, 2021 | 10:00 a.m. – 3:00 p.m. ET
June 30, 2021 | 10:00 a.m. – 3:00 p.m. ET

CARB-X participants include Kevin Outterson, Executive Director, who will be leading a session titled “THE ANTIBIOTICS PIPELINE: PAST, PRESENT, AND FUTURE” on June 29th at 12.05pm ET.
Click here to learn more.
Click here to view the agenda.
Click here to view a live stream of the event.

6th Microbiome Movement - Drug Development Summit
2021-06-29 - 2021-07-01 | Virtual Event, 765 Commonwealth Avenue, Boston, MA, 02215, United States
Welcome to the 6th Microbiome Movement – Drug Development Summit, the most comprehensive forum for microbiome drug developers, the Microbiome Movement!
Continuing to unite the most forward thinking and industry researchers from the biopharmaceutical industry, our unrivaled program will uncover microbiome functionality and mechanisms, advance clinical development, overcome the key CMC challenges, whilst also discovering and applying microbiome biomarkers for improved clinical outcomes. This is THE must attend conference for microbiome drug developers.
Recent clinical successes within the space are paving a way for the first FDA approved microbiome therapeutic, however, there still remains a number of unique scientific and practical challenges that must be overcome to pursue the causal role of the microbiome in disease, and translate the complex science into realized and effective therapies that improve patient outcomes.
Our end-to-end discussion will unite 65+ expert speakers and 250+ key decision-makers to provide you with valuable insights into the latest scientific discoveries and industry progress, to help overcome the obstacles holding back therapeutic approval. This summit provides unique a platform for lasting connections with leaders at the cutting edge of making microbiome therapeutics an effective reality.
The 6th Microbiome Movement – Drug Development Summit is the perfect opportunity for the industry to take a collaborative approach to close the clinical gap, discover the next generation of microbiome-based therapeutics, and establish new partnerships to accelerate your research.
Click here to learn more.
Click here to view the agenda.
Click here to register.

ICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance
2021-06-29 - 2021-06-30 | VIRTUAL EVENT
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers.
ICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Antibiotics and Antibiotic Resistance. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Antibiotics and Antibiotic Resistance
Click here to learn more.
Click here to view the agenda.
Click here to register.

Gordon Research Conference: Antimicrobial Peptides
2021-06-27 - 2021-07-02 | Four Points Sheraton / Holiday Inn Express, 1050 Schooner Drive, Ventura, CA, 93001, United States
Additional details forthcoming.
Click here to learn more.
Click here to register.
